Article

Primary Cutaneous Candida tropicalis Infection in a Patient With B-Cell Lymphoma

Author and Disclosure Information

We report the case of a 61-year-old man with diffuse large B-cell lymphoma who presented with a tender skin lesion on the left side of the flank of 5 weeks’ duration after undergoing myeloablative chemotherapy. Prior treatment with intravenous vancomycin showed minimal response. Clinical examination revealed a tender, indurated, erythematous plaque on the left side of the flank. A skin biopsy demonstrated a lymphohistiocytic and neutrophilic infiltrate with deep dermal necrosis and fungal forms in the dermis and subcutis. A tissue culture grew Candida tropicalis; however, blood cultures remained negative for yeast. A diagnosis of primary cutaneous candidiasis was made based on the lack of response to antibiotics, tissue evidence of C tropicalis, and negative blood cultures. Although rare, primary cutaneous candidiasis should be considered in immunocompromised patients presenting with cellulitis or an abscess that is unresponsive to treatment.


 

Recommended Reading

CDC sounds alarm on hospital antibiotic use
MDedge Dermatology
HIV-1 has gained virulence over the course of the epidemic
MDedge Dermatology
Risk of condomless sex low if HIV-positive partner is well controlled on ART
MDedge Dermatology
Cosmetic Corner: Dermatologists Weigh in on OTC Antifungals
MDedge Dermatology
FDA panel unanimously backs cobas HPV test as primary screening tool
MDedge Dermatology
U.S. tracking of HPV in cervical precancers confirms half due to 16/18
MDedge Dermatology
VIDEO: Try ‘restaurant menu’ approach to laser treatment of scars
MDedge Dermatology
‘Culture of Safety’ best defense against sharps injury
MDedge Dermatology
FDA panel unanimously supports tedizolid phosphate for severe skin infections
MDedge Dermatology
FDA panel endorses antibacterial dalbavancin
MDedge Dermatology

Related Articles